Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Medicine Inc (MMED.NE)

Mind Medicine Inc (MMED.NE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NEO]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NEO]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 375,980
  • Shares Outstanding, K 422,445
  • Annual Sales, $ 0 K
  • Annual Income, $ -93,036 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.97
Trade MMED.NE with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.23
  • Most Recent Earnings -0.04 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.810 +1.23%
on 06/23/22
1.350 -39.26%
on 06/06/22
-0.280 (-25.45%)
since 05/30/22
3-Month
0.810 +1.23%
on 06/23/22
1.530 -46.41%
on 05/04/22
-0.670 (-44.97%)
since 03/30/22
52-Week
0.810 +1.23%
on 06/23/22
4.590 -82.14%
on 07/13/21
-3.490 (-80.97%)
since 06/30/21

Most Recent Stories

More News
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
TSLA : 681.79 (+1.24%)
CYBN : 0.5630 (+0.54%)
MNMD : 0.5830 (-8.92%)
CMPS : 10.80 (-0.18%)
SEEL : 0.6545 (-3.79%)
NUMI.TO : 0.2450 (+2.08%)
NUMIF : 0.1783 (-3.83%)
Oregon to Become the First State to Legally Roll Out Psilocybin

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
CYBN : 0.5630 (+0.54%)
MNMD : 0.5830 (-8.92%)
CMPS : 10.80 (-0.18%)
JNJ : 179.52 (+1.13%)
SEEL : 0.6545 (-3.79%)
Why Psychedelics Could Soon Replace Antidepressants

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
MYCO.NE : 0.820 (+2.50%)
SEEL : 0.6545 (-3.79%)
MNMD : 0.5830 (-8.92%)
CMPS : 10.80 (-0.18%)
MYCOF : 0.7000 (+9.38%)
CYBN : 0.5630 (+0.54%)
Demand for Toad Venom Rises Along With the Booming Psychedelics Market

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – March 30, 2022 –  Depression and anxiety affect millions around the world and the venom of a toad is the latest  psychedelic...

MMED.NE : 0.820 (-5.75%)
MYCO.NE : 0.820 (+2.50%)
NUMI.TO : 0.2450 (+2.08%)
NUMIF : 0.1783 (-3.83%)
SEEL : 0.6545 (-3.79%)
MNMD : 0.5830 (-8.92%)
MYCOF : 0.7000 (+9.38%)
CMPS : 10.80 (-0.18%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage : Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of the nervous system to change...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
CYBN : 0.5630 (+0.54%)
CMPS : 10.80 (-0.18%)
MNMD : 0.5830 (-8.92%)
ATAI : 3.65 (+0.27%)
GHRS : 10.15 (+1.70%)
Psychedelic Therapies Offer Hope for Mental Health

NetworkNewsWire Editorial Coverage   New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
CYBN : 0.5630 (+0.54%)
CMPS : 10.80 (-0.18%)
MNMD : 0.5830 (-8.92%)
ATAI : 3.65 (+0.27%)
GHRS : 10.15 (+1.70%)
Psilocybin and MDMA Get the Green Light for Medical Use in Canada

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – January 19, 2022 –  After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp...

MMED.NE : 0.820 (-5.75%)
NUMI.TO : 0.2450 (+2.08%)
NUMIF : 0.1783 (-3.83%)
CMPS : 10.80 (-0.18%)
ATAI : 3.65 (+0.27%)
RVVTF : 0.3591 (+2.60%)
RVV.CN : 0.460 (+3.37%)
MNMD : 0.5830 (-8.92%)
Mind Medicine (NASDAQ: MNMD) (NEO: MMED) to Study Effect of Time on LSD Microdosing

Mind Medicine (NASDAQ: MNMD) (NEO: MMED) (“MindMed”), a psychedelic medicine biotech company, plans to conduct research on how the time of the day during which an individual consumes microdoses of...

MMED.NE : 0.820 (-5.75%)
MYCO.NE : 0.820 (+2.50%)
MNMD : 0.5830 (-8.92%)
MYCOF : 0.7000 (+9.38%)
North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026

Palm Beach, FL –December 14, 2021 – FinancialNewsMedia.com News Commentary  – The prevalence of mental health disorders has risen exponentially, and the development of novel medications has not...

MMED.NE : 0.820 (-5.75%)
MCUR.CN : 0.080 (unch)
MCURF : 0.0650 (+5.52%)
ATAI : 3.65 (+0.27%)
MNMD : 0.5830 (-8.92%)
CMPS : 10.80 (-0.18%)
FTRP : 0.8400 (-0.01%)
FTRP.TO : 1.04 (-4.59%)
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered

FN Media Group Presents USA News Group News Commentary

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
PRXTF : 0.0277 (+10.80%)
PULL.CN : 0.030 (+20.00%)
CMPS : 10.80 (-0.18%)
ATAI : 3.65 (+0.27%)
CYBN : 0.5630 (+0.54%)
MNMD : 0.5830 (-8.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.870
2nd Resistance Point 0.860
1st Resistance Point 0.840
Last Price 0.820
1st Support Level 0.810
2nd Support Level 0.800
3rd Support Level 0.780

See More

52-Week High 4.590
Fibonacci 61.8% 3.146
Fibonacci 50% 2.700
Fibonacci 38.2% 2.254
Last Price 0.820
52-Week Low 0.810

See More

Business Summary

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar